2-Amino-4-pyrrolidinothieno[2,3-d]pyrimidine-6-carboxylic acid as an N-terminal surrogate in amino acid and peptide analogues

Synthesis

Volumn , Issue 18, 2005, Pages 3159-3166

  Bissyris, Evangelos E ^a   Belekos, Dimitris ^b   Magafa, Vassiliki ^a   Tsoungas, Petros G ^c   Varvounis, George ^b   Cordopatis, Paul ^a  

^a UNIVERSITY OF PATRAS   (Greece)

^b UNIVERSITY OF IOANNINA   (Greece)

^c Ministry of Development   (Greece)

Author keywords

Amino acids; Angiotensin II; Heterocycles; Peptides; Thienopyrimidine

Indexed keywords

HYDROLYSIS; POLYPEPTIDES; SYNTHESIS (CHEMICAL);

HETEROCYCLERS; PEPTIDES; THIENOPYRIMIDINES;

AMINO ACIDS;

2 AMINO 4 PYRROLIDINOTHIENO[2,3 D]PYRIMIDINE 6 CARBOXYLIC ACID; AMINO ACID DERIVATIVE; ANGIOTENSIN; BENZYL 2 AMINO 4 PYRROLIDINOTHIENO[2,3 D]PYRIMIDINE 6 CARBOXYLATE; CARBOXYLIC ACID DERIVATIVE; HETEROCYCLIC COMPOUND; N TERT BUTOXYCARBONYL DERIVATIVE; PEPTIDE DERIVATIVE; PYRIMIDINE DERIVATIVE; THIENO[2,3 D]PYRIMIDINE DERIVATIVE; THIENOPYRIMIDINE DERIVATIVE; UNCLASSIFIED DRUG;

AMINO ACID SYNTHESIS; AMINO TERMINAL SEQUENCE; ARTICLE; HYDROGENOLYSIS; HYDROLYSIS; PEPTIDE SYNTHESIS; PHASE TRANSITION; SOLID;

EID: 28344438936     PISSN: 00397881     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-918426     Document Type: Article

References (34)

1. Matthew, G. B.; Daniel, H. R. J. Med. Chem. 2002, 45, 541.
2. (a) In Advances in Amino Acid Mimetics and Peptidomimetics, Vol. 1; Abell, A., Ed.; JAI Press: Greenwich, 1997.
3. (b) In Advances in Amino Acid Mimetics and Peptidomimetics, Vol. 2; Abell, A., Ed.; JAI Press: Greenwich, 1999.
4. (a) Methods in Molecular Medicine, Peptidomimetics Protocols, Vol. 30; Kazmierski, W. M.; Walker, J. M., Eds.; Human Press: Totowa NJ, 1999.
5. (b) Plant, A.; Stieber, F.; Scherkenbeck, J.; Lösel, P.; Dyker, H. Org. Lett. 2001, 3, 3427.
6. (c) Abell, A. D. Lett. Pept. Sci. 2002, 8, 267.
7. (d) Lampariello, L. A.; Piras, D.; Rodriquez, M.; Taddei, M. J. Org. Chem. 2003, 68, 7893.
8. Roth, B. J. Med. Chem. 1969, 12, 227.
9. (a) Varvounis, G.; Giannopoulos, T. Adv. Heterocycl. Chem. 1996, 66, 193.
10. (b) Eguchi, J.; Saitoh, Y.; Egawa, M.; Saito, K. I.; Kawamura, H. Pharmacol., Biochem. Behav. 1997, 56, 229.
11. (c) Modica, M.; Santagati, M.; Russo, F.; Parotti, L.; Gioia, L.; Selvaggini, C.; Salmona, M.; Mennini, T. J. Med. Chem. 1997, 40, 574.
12. (d) Katada, J.; Iijima, K.; Muramatsu, M.; Takami, M.; Yasuda, E.; Hayashi, M.; Hattori, M.; Hayashi, Y. Bioorg. Med. Chem. Lett. 1999, 9, 797.
13. (e) Panico, A.; Cardile, V.; Santagati, A.; Gentile, B. Farmaco 2001, 56, 959.
14. (f) Sasaki, S.; Cho, N.; Nara, Y.; Harada, M.; Endo, S.; Suzuki, N.; Furuya, S.; Fujino, M. J. Med. Chem. 2003, 46, 113.
15. (g) Munchhof, M. J.; Beebe, J. S.; Casavant, J. M.; Cooper, B. A.; Doty, J. L.; Higdon, R. C.; Hillerman, S. M.; Soderstrom, C. I.; Knauth, E. A.; Marx, M. A.; Rossi, A. M. K.; Sobolov, S. B.; Sun, J. Bioorg. Med. Chem. Lett. 2004, 14, 21.
16. (a) Regoli, D.; Park, W. K.; Rioux, F. Pharmacol. Rev. 1974, 26, 69.
17. (b) Khosla, M. C.; Smeby, R. R.; Bumpus, F. M. In Handbook of Experimental Pharmacology, Angiotensin; Page, I. H.; Bumpus, F. M., Eds.; Springer Verlag: Berlin, 1974.
18. (c) Hardman, J. G.; Goodman Gilmon, A.; Limbird, L. E. In Goodman & Gilman's The Pharmacological Basis of Therapeutics, 9th ed.; McGraw-Hill Companies: New York, 1996.
19. (d) Miura, S.; Feng, Y.-H.; Husain, A.; Karnik, S.S.J. Biol. Chem. 1999, 274, 7103; and refs therein.
20. Clark, J.; Korakas, D.; Shahhet, M. S.; Varvounis, G. J. Heterocycl. Chem. 1993, 30, 1065.
21. (a) Cordopatis, P.; Manessi-Zoupa, E.; Bosse, R.; Bouley, R.; Gagnon, S.; Escher, E. Int. J. Pept. Protein Res. 1994, 44, 320.
22. (b) Cordopatis, P.; Theodoropoulos, D.; Escher, E. In Bioactive Peptides in Drug Discovery and Design; Matsoukas, J.; Mavromoustakos, T., Eds.; IOS Press: Amsterdam, 1999.
23. (c) Zalcberg, H.; Assimomytis, N.; Magafa, V.; Manessi-Zoupa, E.; Cordopatis, P.; Shimuta, S. I. J. Pept. Res. 1999, 53, 678.
24. (d) Assimomytis, N.; Magafa, V.; Manessi-Zoupa, E.; Theodoropoulos, D.; Cordopatis, P.; Perodin, J.; Bouley, R.; Escher, E. Arzneimittelforschung/Drug Res. 2000, 50, 526.
25. Spyroulias, G. A.; Nikolakopoulou, P.; Tzakos, A.; Gerothanassis, I. P.; Magafa, V.; Manessi-Zoupa, E.; Cordopatis, P. Eur. J. Biochem. 2003, 270, 2163.
26. Mohamadi, F.; Richards, N. G. J.; Guida, W. C.; Liskamp, R.; Caufield, C.; Chang, G.; Hendrickson, T.; Still, W. C. J. Comput. Chem. 1990, 11, 440.
27. Kolossvary, I.; Guida, W. C. J. Am. Chem. Soc. 1996, 118, 5011.
28. Armarego, W. L. F.; Perrin, D. D. Purification of Laboratory Chemicals; Butterworth-Heinemann: Oxford, 1996.
29. Karagiannis, K.; Stavropoulos, G.; Poulos, C.; Jordan, C. C.; Hagan, R. M. Int. J. Pept. Protein Res. 1993, 42, 565.
30. R = 25.95 min according to: Baumeister, B.; Matile, S. Chem. Eur. J. 2000, 6, 1739.
31. Barlos, K.; Chatzi, O.; Gatos, D.; Stavropoulos, G. Int. J. Pept. Protein Res. 1991, 37, 513.
32. Bernatowitz, M. S.; Daniels, S. B.; Köster, H. Tetrahedron Lett. 1989, 30, 4645.
33. Kaiser, E.; Colescott, R. L.; Bossinger, C. D.; Cook, P. I. Anal. Biochem. 1970, 34, 595.
34. Christensen, T. Acta Chem. Scand., Ser. B 1979, 33, 763.